These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30138062)

  • 1. HIV Preexposure Prophylaxis Initiation at a Large Community Clinic: Differences Between Eligibility, Awareness, and Uptake.
    Shover CL; Javanbakht M; Shoptaw S; Bolan RK; Lee SJ; Parsons JT; Rendina J; Gorbach PM
    Am J Public Health; 2018 Oct; 108(10):1408-1417. PubMed ID: 30138062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
    Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men.
    Grov C; Whitfield TH; Rendina HJ; Ventuneac A; Parsons JT
    AIDS Behav; 2015 Dec; 19(12):2234-44. PubMed ID: 25735243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Utilization of Pre-Exposure Prophylaxis (PrEP) and Meningococcal Vaccine (MenACWY) Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles County, California.
    Holloway IW; Tan D; Bednarczyk RA; Fenimore VL; Randall L; Lutz CS; Frew PM
    Arch Sex Behav; 2020 Jan; 49(1):137-146. PubMed ID: 31628630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Pre-exposure Prophylaxis (PrEP) Uptake Among Gay and Bisexual Men in Australia and Factors Associated With the Nonuse of PrEP Among Eligible Men: Results From a Prospective Cohort Study.
    Hammoud MA; Vaccher S; Jin F; Bourne A; Maher L; Holt M; Bavinton BR; Haire B; Degenhardt L; Grulich A; Prestage GP
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e73-e84. PubMed ID: 30973548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Screening and Enrollment of People at Risk of HIV in Mexico's Preexposure Prophylaxis Demonstration Project, 2018-2020.
    Vermandere H; Martínez-Silva G; Aguilera-Mijares S; Martínez-Dávalos A; Bautista-Arredondo S
    Public Health Rep; 2024; 139(5):606-614. PubMed ID: 38491784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands.
    Hulstein SH; Matser A; van der Loeff MFS; Hoornenborg E; Prins M; de Vries HJC
    Sex Transm Dis; 2021 Feb; 48(2):86-93. PubMed ID: 32932386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
    Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
    Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
    Cohen SE; Vittinghoff E; Bacon O; Doblecki-Lewis S; Postle BS; Feaster DJ; Matheson T; Trainor N; Blue RW; Estrada Y; Coleman ME; Elion R; Castro JG; Chege W; Philip SS; Buchbinder S; Kolber MA; Liu AY
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):439-48. PubMed ID: 25501614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low awareness but high acceptability of pre-exposure prophylaxis for HIV among men who have sex with men and transgender persons in Delhi, India.
    Sethi AK; Haldar P; Rai SK; Kant S; Rajan S; Kumar P; Mishra JK; Singh B
    Int J STD AIDS; 2023 Oct; 34(11):763-776. PubMed ID: 37269245
    [No Abstract]   [Full Text] [Related]  

  • 15. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
    Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
    Iniesta C; Álvarez-Del Arco D; García-Sousa LM; Alejos B; Díaz A; Sanz N; Garrido J; Meulbroek M; Pujol F; Moreno S; Fuster-Ruiz de Apocada MJ; Coll P; Antela A; Del Romero J; Ayerdi O; Riera M; Hernández J; Del Amo J
    PLoS One; 2018; 13(10):e0204738. PubMed ID: 30339690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men.
    Morgan J; Ferlatte O; Salway T; Wilton J; Hull M
    Can J Public Health; 2018 Dec; 109(5-6):791-799. PubMed ID: 29981103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.